Chemokines in tumor angiogenesis and metastasis
- PMID: 17828470
- PMCID: PMC4237067
- DOI: 10.1007/s10555-007-9068-9
Chemokines in tumor angiogenesis and metastasis
Abstract
Chemokines are a large group of low molecular weight cytokines that are known to selectively attract and activate different cell types. Although the primary function of chemokines is well recognized as leukocyte attractants, recent evidences indicate that they also play a role in number of tumor-related processes, such as growth, angiogenesis and metastasis. Chemokines activate cells through cell surface seven trans-membranes, G-protein-coupled receptors (GPCR). The role played by chemokines and their receptors in tumor pathophysiology is complex as some chemokines favor tumor growth and metastasis, while others may enhance anti-tumor immunity. These diverse functions of chemokines establish them as key mediators between the tumor cells and their microenvironment and play critical role in tumor progression and metastasis. In this review, we present some of the recent advances in chemokine research with special emphasis on its role in tumor angiogenesis and metastasis.
Figures


Similar articles
-
Chemokines and their role in tumor growth and metastasis.J Immunol Methods. 1998 Nov 1;220(1-2):1-17. doi: 10.1016/s0022-1759(98)00128-8. J Immunol Methods. 1998. PMID: 9839921 Review.
-
Chemokines in tumor progression and metastasis.Cancer Sci. 2005 Jun;96(6):317-22. doi: 10.1111/j.1349-7006.2005.00059.x. Cancer Sci. 2005. PMID: 15958053 Free PMC article. Review.
-
Chemokines.Recent Results Cancer Res. 2010;180:35-50. doi: 10.1007/978-3-540-78281-0_4. Recent Results Cancer Res. 2010. PMID: 20033377 Review.
-
The role of chemokines and their receptors in angiogenesis.Cell Mol Life Sci. 2011 Sep;68(17):2811-30. doi: 10.1007/s00018-011-0677-7. Epub 2011 Apr 9. Cell Mol Life Sci. 2011. PMID: 21479594 Free PMC article. Review.
-
The chemokine system -- a major regulator of angiogenesis in health and disease.APMIS. 2004 Jul-Aug;112(7-8):481-95. doi: 10.1111/j.1600-0463.2004.apm11207-0808.x. APMIS. 2004. PMID: 15563311 Review.
Cited by
-
Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.BMC Cancer. 2016 May 12;16:305. doi: 10.1186/s12885-016-2340-z. BMC Cancer. 2016. PMID: 27175473 Free PMC article.
-
The DARC Side of Inflamm-Aging: Duffy Antigen Receptor for Chemokines (DARC/ACKR1) as a Potential Biomarker of Aging, Immunosenescence, and Breast Oncogenesis among High-Risk Subpopulations.Cells. 2022 Nov 29;11(23):3818. doi: 10.3390/cells11233818. Cells. 2022. PMID: 36497078 Free PMC article. Review.
-
Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo.Cancer Sci. 2013 Nov;104(11):1523-31. doi: 10.1111/cas.12279. Epub 2013 Oct 14. Cancer Sci. 2013. PMID: 24033560 Free PMC article.
-
Chronic Pancreatitis and the Development of Pancreatic Cancer.Endocr Metab Immune Disord Drug Targets. 2020;20(8):1182-1210. doi: 10.2174/1871530320666200423095700. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 32324526 Free PMC article. Review.
-
Identification of GRO1 as a critical determinant for mutant p53 gain of function.J Biol Chem. 2009 May 1;284(18):12178-87. doi: 10.1074/jbc.M900994200. Epub 2009 Mar 3. J Biol Chem. 2009. PMID: 19258312 Free PMC article.
References
-
- Fidler IJ. The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nature Review Cancer. 2003;3(6):453–458. - PubMed
-
- Locati M, Otero K, Schioppa T, Signorelli P, Perrier P, Baviera S, et al. The chemokine system: Tuning and shaping by regulation of receptor expression and coupling in polarized responses. Allergy. 2002;57(11):972–982. - PubMed
-
- Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacological Reviews. 2000;52(1):145–176. - PubMed
-
- Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12(2):121–127. - PubMed
-
- Murphy PM. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacological Reviews. 2002;54(2):227–229. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources